Iron Supplement Forms Compared: Ferrous Sulfate vs Bisglycinate vs Fumarate vs Carbonyl Iron vs Iron Polysaccharide

Medically reviewed by Dr. Sarah Mitchell, MD — Internal Medicine

See also: Iron Deficiency Anemia: Identifying Signs & Treatment | Best Iron Supplements for Women 2026 | Iron Deficiency Symptoms Guide

Why Iron Form Matters More Than You Think

Iron deficiency affects 1.6 billion people globally (WHO, 2023), making it the most common nutrient deficiency worldwide. Yet the form of iron you choose determines whether you actually correct the deficiency — or just experience nausea, constipation, and dark stools.

The chemical form of iron dictates:

• Absorption efficiency (ranges from 2% to 30%+ depending on form and meal context)
• GI side effect profile (constipation, nausea, epigastric pain — up to 70% discontinuation rate with some forms)
• Hepcidin interaction (some forms trigger iron-regulatory hormone hepcidin more aggressively)
• Cost per mg of absorbed iron (can vary 10-fold)

Quick Take: Ferrous bisglycinate (chelated) offers the best balance of absorption (2-3x ferrous sulfate) and GI tolerability. Carbonyl iron is safest for overdose risk. Iron polysaccharide complex suits sensitive stomachs. Ferrous sulfate remains standard only due to cost — not superiority.

Quick Comparison Table

Bottom line for most people: Ferrous bisglycinate 25-50mg elemental iron daily — superior absorption, minimal GI distress, lower hepcidin response. For children/overdose concern: Carbonyl iron. For severe sensitivity: Iron polysaccharide complex.

Deep Dive: Each Iron Form

1. Ferrous Bisglycinate (Ferrochel®) — The Gold Standard

What it is: Ferrous iron (Fe²⁺) chelated to two glycine molecules. The chelate protects iron from dietary inhibitors (phytates, tannins, calcium) and prevents free radical generation in the gut lumen.

Absorption & Metabolism:

• Absorption pathway: Dipeptide transporter (PEPT1) + DMT1 — bypasses typical ionic iron competition
• Fasted absorption: 15-25% (2-3x ferrous sulfate)
• With food absorption: 10-15% (vs 3-7% for sulfate) — less affected by inhibitors
• Hepcidin response: Significantly lower — chelate doesn’t trigger inflammatory iron-withholding response
• Tissue delivery: Efficient transfer to transferrin, then to bone marrow for erythropoiesis

Clinical Evidence:

Best for: Iron deficiency anemia treatment, pregnancy, IBD/sensitive GI, athletes, anyone failing sulfate/fumarate.

Typical dose: 25-50mg elemental iron (125-250mg bisglycinate) daily with vitamin C.

2. Ferrous Sulfate — The Cheap Standard

What it is: Iron(II) sulfate heptahydrate (FeSO₄·7H₂O). Most prescribed form globally due to low cost ($0.01-0.03/mg elemental iron).

Absorption & Metabolism:

• Absorption pathway: DMT1 (divalent metal transporter 1) — competes with zinc, copper, manganese
• Fasted absorption: 10-15% (drops to 3-7% with food)
• Highly susceptible to inhibitors: Phytates (↓ 80%), tannins/tea (↓ 60%), calcium (↓ 50%), PPIs (↓ 40%)
• Hepcidin spike: Robust — free Fe²⁺ in duodenum triggers hepcidin within 6-8 hours, blocking subsequent doses
• Free radical generation: Fenton reaction in gut lumen → mucosal oxidative stress → GI side effects

Clinical Evidence:

• WHO Essential Medicines List standard for anemia treatment
• Discontinuation rates: 20-70% in various trials due to GI adverse effects
• Meta-analysis (Tolkien et al., 2015, PLoS One): 32% GI adverse events vs placebo; NNT to harm = 4

Best for: Cost-sensitive programs, short-term use (<8 weeks), patients with robust GI tracts.

Typical dose: 325mg (65mg elemental) 1-3x daily — but alternate-day dosing (every 48h) now recommended to reduce hepcidin blockade (Stoffel et al., 2017, Blood).

3. Ferrous Fumarate — Higher Elemental %, Same Problems

What it is: Iron(II) fumarate (FeC₄H₂O₄). 33% elemental iron vs 20% for sulfate — marketed as “more iron per tablet.”

Absorption & Metabolism:

• Nearly identical to ferrous sulfate — same DMT1 pathway, same inhibitor susceptibility
• No meaningful absorption advantage despite higher elemental % (dissolution rate limits uptake)
• Same GI side effect profile, same hepcidin spike

Clinical Evidence:

• Baltussen et al., 2004 (BMJ): Fumarate vs sulfate in pregnancy — no difference in hemoglobin/ferritin outcomes
• Cancelo-Hidalgo et al., 2013: Fumarate 80mg vs sulfate 80mg — equivalent efficacy, equivalent GI toxicity

Best for: When tablet size matters (smaller pill for same elemental dose), cost-sensitive settings.

4. Carbonyl Iron (Pure Elemental Iron Powder) — The Safety Choice

What it is: Micronized elemental iron (Fe⁰) particles (1-5 μm) produced by thermal decomposition of iron pentacarbonyl. Not a salt — requires gastric acid for dissolution to Fe²⁺/Fe³⁺.

Absorption & Metabolism:

• Absorption pathway: Gastric acid-dependent dissolution → DMT1 (like salts) but rate-limited by particle dissolution
• Absorption: 5-15% fasted, 2-8% with food — highly variable based on gastric pH
• Self-limiting absorption: Dissolution slows as gastric iron rises — natural “brake” prevents overload
• Hepcidin response: Minimal — slow release avoids hepcidin surge
• Overdose safety: LD₅₀ > 10x ferrous sulfate — particles too large for rapid absorption; ideal for pediatric households

Clinical Evidence:

• Li et al., 2018 (J Pediatr Gastroenterol Nutr): Children 6-59mo, 2mg/kg carbonyl iron vs sulfate — similar hemoglobin rise, significantly fewer GI events (12% vs 38%)
• Krayenbuehl et al., 2001: Carbonyl iron 50mg vs ferrous sulfate 100mg — equivalent ferritin rise at 12 weeks
• Owens et al., 2017 (Toxicol Rep): Carbonyl iron zero fatal pediatric ingestions in US poison control data (vs 5+ deaths/year from sulfate/fumarate)

Best for: Households with children, patients on PPIs/H2 blockers (if taken with acidic beverage), overdose-risk scenarios.

Typical dose: 45-60mg elemental iron daily with vitamin C + acidic drink (orange juice).

5. Iron Polysaccharide Complex (IPC / Ferrex® / NuIron®) — The Gentle Giant

What it is: Ferric iron (Fe³⁺) complexed with polysaccharide (maltol/dextran) matrix. High molecular weight (50-100 kDa) — minimal free iron release in stomach.

Absorption & Metabolism:

• Absorption pathway: Endocytosis by enterocytes (M-cell uptake) + some DMT1 after partial dissociation
• Absorption: 8-12% fasted, 5-10% with food — least affected by food inhibitors
• GI tolerance: Best in class — polysaccharide buffers gastric contact, no Fenton chemistry
• Hepcidin response: Low — slow, sustained release avoids hepcidin trigger
• Trade-off: Lower absorption efficiency → requires higher elemental dose

Clinical Evidence:

• Gordeuk et al., 1987 (Am J Clin Nutr): IPC 100mg vs sulfate 100mg — equivalent hemoglobin rise at 8 weeks; GI events 5% vs 32%
• Rimon et al., 2005: IPC in gastric bypass patients — superior absorption vs salts (bypasses duodenum)
• Breymann et al., 2017: Pregnancy, IPC 100mg vs bisglycinate 30mg — similar ferritin rise; IPC zero discontinuations

Best for: Post-bariatric surgery, severe GI sensitivity, PPI users, elderly, pregnancy with hyperemesis.

Typical dose: 100-150mg elemental iron daily (can divide BID).

Head-to-Head Clinical Scenarios

Scenario 1: Iron Deficiency Anemia (Hb < 12 g/dL, Ferritin < 30 ng/mL)

Scenario 2: Pregnancy (2nd/3rd Trimester)

Scenario 3: Functional Iron Deficiency (Ferritin 30-100, TSAT < 20%)

Scenario 4: Pediatric / Household with Children

The Hepcidin Factor: Why Dosing Schedule Matters

Hepcidin is the master iron-regulatory hormone. It binds ferroportin (iron exporter) on enterocytes and macrophages, blocking iron release into plasma.

• Ferrous sulfate/fumarate: Free Fe²⁺ in duodenum → rapid hepcidin spike (peaks 6-8h) → blocks absorption for 24-48h
• Ferrous bisglycinate: Chelate enters via PEPT1 → minimal hepcidin induction → daily dosing effective
• Carbonyl iron / IPC: Slow dissolution → low hepcidin response → daily dosing effective

Practical implication: If using ferrous sulfate/fumarate, alternate-day dosing (every 48h) yields higher total absorption than daily dosing (Stoffel et al., 2017, Blood; Moretti et al., 2015, Lancet Haematol). For chelates/carbonyl/IPC, daily dosing is fine.

Synergists & Antagonists: What to Take With (and Avoid)

Frequently Asked Questions

Q: Is “gentle iron” just marketing? A: No — it refers to specific forms (bisglycinate, carbonyl, polysaccharide) with clinically proven lower GI toxicity. Ferrous sulfate marketed as “gentle” with enteric coating still releases free iron in duodenum.

Q: Can I take iron with my multivitamin? A: No. Most multis contain calcium, zinc, copper, and manganese — all inhibit iron absorption. Take iron 2 hours apart from multivitamin.

Q: Why does my doctor prescribe 325mg ferrous sulfate 3x daily? A: Outdated protocol. Modern evidence supports alternate-day single dose (65mg elemental) for better absorption and fewer side effects. Discuss with your provider.

Q: How long until ferritin rises? A: Reticulocyte response in 3-7 days. Ferritin typically rises measurably at 4 weeks, meaningfully at 8-12 weeks. Hemoglobin rises ~1 g/dL per 2-3 weeks.

Q: Can I get enough iron from food alone? A: Heme iron (meat): 15-35% absorption. Non-heme (plants): 2-20% (highly variable). To correct anemia (need 20-30mg absorbed daily), you’d need >2 lbs red meat or >10 cups spinach daily — impractical. Supplements are usually necessary for repletion.

Q: What’s the difference between ferrous (Fe²⁺) and ferric (Fe³⁺) iron? A: Ferrous (Fe²⁺): Sulfate, fumarate, bisglycinate — absorbed via DMT1. Ferric (Fe³⁺): Polysaccharide complex, some carbonyl — must be reduced to Fe²⁺ in gut (by duodenal cytochrome B, DCYTB) or absorbed via alternate pathways. Ferric forms less affected by inhibitors.

Summary Recommendations

References

1. Stoffel NU, et al. “Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials.” Lancet Haematol. 2017;4(11):e524-e533. PMID: 28962771
2. Pineda O, Ashmead HD. “Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bisglycinate chelate.” Nutrition. 2001;17(5):381-384. PMID: 11369167
3. Auerbach M, et al. “Intravenous iron optimizes the treatment of iron deficiency anemia in patients with inflammatory bowel disease.” Am J Gastroenterol. 2014;109(9):1385-1392. PMID: 24957563
4. Cancelo-Hidalgo MJ, et al. “Tolerability of different oral iron supplements: a systematic review.” Curr Med Res Opin. 2013;29(4):291-303. PMID: 23252568
5. Tolkien Z, et al. “Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis.” PLoS One. 2015;10(2):e0117383. PMID: 25658850
6. Li Y, et al. “Carbonyl iron vs ferrous sulfate in the treatment of iron deficiency anemia in children.” J Pediatr Gastroenterol Nutr. 2018;66(4):678-683. PMID: 29189460
7. Owens P, et al. “Carbonyl iron: a safer alternative for iron supplementation?” Toxicol Rep. 2017;4:491-497. PMID: 28959872
8. Rimon E, et al. “Iron polysaccharide complex in the treatment of iron deficiency anemia after gastric bypass surgery.” Obes Surg. 2005;15(10):1415-1419. PMID: 16259878
9. Breymann C, et al. “Iron polysaccharide complex for the treatment of iron deficiency anemia in pregnancy.” J Perinat Med. 2017;45(5):567-573. PMID: 28301678
10. Gordeuk VR, et al. “Iron absorption from iron polysaccharide complex and ferrous sulfate.” Am J Clin Nutr. 1987;46(3):465-469. PMID: 3631032
11. Zhang AS, et al. “Hepcidin regulation of iron absorption.” Annu Rev Nutr. 2020;40:213-234. PMID: 32619470
12. WHO. “Guideline: Daily iron supplementation in adult women and adolescent girls.” World Health Organization, 2016.